EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Comorbidities and Healthcare Utilization in 4197 Patients With Prurigo Nodularis in Israel: A Cross‐Sectional Population‐Based Analysis

Yuliya Valdman-Grinshpoun, Andrea Zaga, Arnon Dov Cohen iD, Yochai Schonmann, Tali Czarnowicki iD

International Journal of Dermatology · 2025

DOI: 10.1111/ijd.70107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Dermatology, 2025. Verfasst von Yuliya Valdman-Grinshpoun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Soroka University Medical Center, Beer-Sheva, Israel. Hauptthemen laut MEDLINE: Prurigo, Patient Acceptance of Health Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prurigo nodularis patients face a significant burden of comorbidities, necessitating a comprehensive approach to care. We aimed to explore the association between prurigo nodularis, its comorbid conditions, and healthcare usage patterns.

Methods

A population‐based, cross‐sectional study was conducted using the computerized medical data of Clalit Health Service, the largest health maintenance organization in Israel. We extracted data on all database members with prurigo nodularis between the years 2000 and 2022. Data was gathered from various sources, including primary care and hospital reports, as well as laboratory and imaging analyses. We compared 4197 prurigo nodularis patients with 40,771 matched controls (age, gender, socioeconomic status, ethnicity). Logistic regression was used to calculate odds ratios (OR) for comorbidities. Healthcare utilization and medication claims were also analyzed.

Results

This study involved 4197 prurigo nodularis patients. Prurigo nodularis showed strong associations with various cutaneous and systemic comorbidities, mainly atopic dermatitis (odds ratio [OR] 5.74, 99.5% confidence interval [CI]: 4.85–6.80, p < 0.001), chronic renal failure and dialysis (OR 1.41, 99.5% CI: 1.15–1.72, p < 0.001), as well as a myriad of mental health disorders. Prurigo nodularis patients exhibited increased healthcare utilization and medication claims.

Conclusions

This study highlights the substantial comorbidity burden in prurigo nodularis patients, emphasizing the need for a holistic care approach. The study also underscores the importance of psychological screening and highlights the burden that prurigo nodularis and its associated disorders place on healthcare utilization. Future studies that include further research into prurigo nodularis pathogenesis and treatment strategies considering its systemic associations are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PrurigoPatient Acceptance of Health CareHumansIsraelCross-Sectional StudiesMaleFemaleMiddle AgedAdultComorbidityAgedYoung AdultAdolescentDermatitis, AtopicCase-Control StudiesChild

Stichwörter der Autor:innen

comorbiditiesgeneral dermatologyhealthcare utilizationprurigo nodularis

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, Soroka University Medical Center, Beer-Sheva, Israel.
  • Department of Quality Measures and Research, Clalit Health Services, Tel Aviv, Israel.
  • Siaal Research Center for Family Medicine and Primary Care, the Haim Doron Division of Community Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Dermatology Clinic, Wolfson Medical Center, Holon, Israel.
  • Shaare Zedek Medical Center, the Hebrew University of Jerusalem, Jerusalem, Israel.
  • Department of Dermatology Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.

ORCID-Profile: Arnon Dov Cohen, Tali Czarnowicki

Zitieren

APA

Valdman-Grinshpoun, Y., Zaga, A., Cohen, A. D., Schonmann, Y., & Czarnowicki, T. (2025). Comorbidities and Healthcare Utilization in 4197 Patients With Prurigo Nodularis in Israel: A Cross‐Sectional Population‐Based Analysis. International Journal of Dermatology. https://doi.org/10.1111/ijd.70107

Vancouver

Valdman-Grinshpoun Y, Zaga A, Cohen AD, Schonmann Y, Czarnowicki T. Comorbidities and Healthcare Utilization in 4197 Patients With Prurigo Nodularis in Israel: A Cross‐Sectional Population‐Based Analysis. International Journal of Dermatology. 2025. doi:10.1111/ijd.70107

BibTeX
@article{ValdmanGrinshpoun2025,
  author = {Valdman-Grinshpoun, Yuliya and Zaga, Andrea and Cohen, Arnon Dov and Schonmann, Yochai and Czarnowicki, Tali},
  title = {Comorbidities and Healthcare Utilization in 4197 Patients With Prurigo Nodularis in Israel: A Cross‐Sectional Population‐Based Analysis},
  journal = {International Journal of Dermatology},
  year = {2025},
  doi = {10.1111/ijd.70107}
}
Kostenlos starten →